ETF Holdings Breakdown of NUVB

Stock Name	Nuvation Bio Inc
Ticker	NUVB(USD) NYSE
TYPE	Common Stock
Country	USA
ISIN	US67080N1019

NUVB institutional holdings

The following institutional investment holdings of NUVB have been identified

Date ETF ISIN/Name Num Shares Book value
2025-10-17 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 141,493 USD 482,491

2025-10-17 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 301,778 USD 1,029,063

2025-10-17 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 5,415 USD 18,465

Total = 448,686 USD 1,530,019
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-10-17	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	141,493	USD 482,491
2025-10-17	IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc))	301,778	USD 1,029,063
2025-10-17	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	5,415	USD 18,465
Total =	448,686	USD 1,530,019

News associated with NUVB

Nuvation Bio (NYSE:NUVB) Earns “Outperform” Rating from Wedbush: Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “outperform” rating reissued by equities researchers at Wedbush in a report released on Monday,Benzinga reports. They currently have a $6.00 price target on the stock. Wedbush’s price target indicates a potential upside of 79.10% from the stock’s current price. A number of other research firms […] - 2025-09-10 02:54:50
Nuvation Bio (NYSE:NUVB) Stock Rating Upgraded by Wall Street Zen: Nuvation Bio (NYSE:NUVB – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a note issued to investors on Sunday. Other equities analysts also recently issued research reports about the stock. Royal Bank Of Canada lifted their target price on shares of […] - 2025-08-19 02:46:54
Teacher Retirement System of Texas Sells 5,636 Shares of Nuvation Bio Inc. (NYSE:NUVB): Teacher Retirement System of Texas decreased its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 8.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 58,866 shares of the company’s stock after selling 5,636 shares during the quarter. Teacher Retirement […] - 2025-07-22 04:16:50
Nuvation Bio Inc. (NYSE:NUVB) Receives $7.17 Consensus Price Target from Brokerages: Shares of Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) have received an average rating of “Buy” from the five brokerages that are presently covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average […] - 2025-07-10 02:19:09
Wealth Enhancement Advisory Services LLC Takes Position in Nuvation Bio Inc. (NYSE:NUVB): Wealth Enhancement Advisory Services LLC acquired a new position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 10,140 shares of the company’s stock, valued at approximately $27,000. A number of other hedge funds also recently added to or reduced their stakes in NUVB. BNP Paribas Financial […] - 2025-06-19 04:36:44
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 122,187 Shares of Nuvation Bio Inc. (NYSE:NUVB): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 54.2% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 347,806 shares of the company’s stock after purchasing an […] - 2025-06-11 04:36:52
Wellington Management Group LLP Grows Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB): Wellington Management Group LLP raised its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 8.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 676,024 shares of the company’s stock after buying an additional 52,051 shares during the period. Wellington Management Group LLP’s holdings in Nuvation Bio were worth $1,798,000 […] - 2025-06-06 05:04:54
Nuvation Bio (NYSE:NUVB) Earns Market Outperform Rating from JMP Securities: Nuvation Bio (NYSE:NUVB – Get Free Report)‘s stock had its “market outperform” rating restated by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They presently have a $6.00 target price on the stock. JMP Securities’ price target would suggest a potential upside of 144.40% from the company’s current price. NUVB has […] - 2025-06-04 02:50:56
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Two Sigma Advisers LP: Two Sigma Advisers LP cut its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 10.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 476,400 shares of the company’s stock after selling 57,500 shares during the period. Two Sigma Advisers […] - 2025-06-01 07:12:50
Nuveen Asset Management LLC Has $4.08 Million Holdings in Nuvation Bio Inc. (NYSE:NUVB): Nuveen Asset Management LLC lowered its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 2.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,534,125 shares of the company’s stock after selling 46,270 shares during the quarter. Nuveen Asset Management LLC’s holdings in Nuvation Bio were worth $4,081,000 as of its […] - 2025-06-01 05:44:57
Nuvation Bio Inc. (NYSE:NUVB) Shares Sold by Dimensional Fund Advisors LP: Dimensional Fund Advisors LP trimmed its holdings in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 26.1% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 1,227,152 shares of the company’s stock after selling 432,720 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Nuvation Bio were worth $3,264,000 at the […] - 2025-05-14 04:44:52
Nuvation Bio Inc. (NYSE:NUVB) Shares Purchased by Price T Rowe Associates Inc. MD: Price T Rowe Associates Inc. MD boosted its holdings in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 4.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 225,025 shares of the company’s stock after buying an additional 9,758 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Nuvation Bio were […] - 2025-05-13 04:32:47
Hsbc Holdings PLC Buys 25,870 Shares of Nuvation Bio Inc. (NYSE:NUVB): Hsbc Holdings PLC boosted its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 22.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 143,223 shares of the company’s stock after buying an additional 25,870 shares during the quarter. Hsbc Holdings PLC’s […] - 2025-05-09 06:18:53
Nuvation Bio (NYSE:NUVB) Trading Down 8.2% on Insider Selling: Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) shares fell 8.2% during mid-day trading on Tuesday following insider selling activity. The company traded as low as $2.18 and last traded at $2.19. 1,169,900 shares changed hands during trading, a decline of 45% from the average session volume of 2,140,547 shares. The stock had previously closed […] - 2025-05-08 02:42:49
Invesco Ltd. Buys 7,344 Shares of Nuvation Bio Inc. (NYSE:NUVB): Invesco Ltd. grew its stake in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 2.3% during the fourth quarter, Holdings Channel reports. The institutional investor owned 330,388 shares of the company’s stock after buying an additional 7,344 shares during the period. Invesco Ltd.’s holdings in Nuvation Bio were worth $879,000 as of its […] - 2025-05-02 05:54:49
XTX Topco Ltd Has $28,000 Holdings in Nuvation Bio Inc. (NYSE:NUVB): XTX Topco Ltd decreased its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 92.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,585 shares of the company’s stock after selling 121,444 shares during the period. XTX Topco […] - 2025-05-02 04:37:18
Legal & General Group Plc Raises Holdings in Nuvation Bio Inc. (NYSE:NUVB): Legal & General Group Plc lifted its stake in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 38.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 224,827 shares of the company’s stock after purchasing an additional 62,877 shares during the quarter. Legal & General […] - 2025-04-29 05:24:52
Renaissance Technologies LLC Sells 462,200 Shares of Nuvation Bio Inc. (NYSE:NUVB): Renaissance Technologies LLC reduced its position in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 44.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 566,800 shares of the company’s stock after selling 462,200 shares during the quarter. Renaissance Technologies LLC’s […] - 2025-04-29 04:44:59
Brokerages Set Nuvation Bio Inc. (NYSE:NUVB) PT at $7.83: Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) has been given an average rating of “Buy” by the six research firms that are presently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year […] - 2025-04-28 03:08:51
ExodusPoint Capital Management LP Has $206,000 Stock Holdings in Nuvation Bio Inc. (NYSE:NUVB): ExodusPoint Capital Management LP reduced its position in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 6.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,280 shares of the company’s stock after selling 5,167 shares […] - 2025-04-14 04:46:55
KLP Kapitalforvaltning AS Makes New Investment in Nuvation Bio Inc. (NYSE:NUVB): KLP Kapitalforvaltning AS bought a new stake in shares of Nuvation Bio Inc. (NYSE:NUVB – Free Report) in the fourth quarter, Holdings Channel.com reports. The fund bought 43,500 shares of the company’s stock, valued at approximately $116,000. A number of other hedge funds have also recently made changes to their positions in NUVB. Abacus Planning […] - 2025-04-10 04:20:48
Connor Clark & Lunn Investment Management Ltd. Buys 25,524 Shares of Nuvation Bio Inc. (NYSE:NUVB): Connor Clark & Lunn Investment Management Ltd. increased its holdings in Nuvation Bio Inc. (NYSE:NUVB – Free Report) by 6.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 422,260 shares of the company’s stock after buying an additional 25,524 shares during […] - 2025-03-21 06:59:10
Nuvation Bio Sees Unusually High Options Volume (NYSE:NUVB): Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) saw some unusual options trading on Thursday. Stock investors acquired 7,110 put options on the company. This represents an increase of approximately 7,800% compared to the typical daily volume of 90 put options. Wall Street Analysts Forecast Growth NUVB has been the subject of a number of […] - 2025-03-21 04:36:49
HC Wainwright Lowers Nuvation Bio (NYSE:NUVB) Price Target to $10.00: Nuvation Bio (NYSE:NUVB – Free Report) had its target price trimmed by HC Wainwright from $11.00 to $10.00 in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Royal Bank of Canada reissued an “outperform” […] - 2025-03-11 04:58:44

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.